公开(公告)号：US11173055B2

公开(公告)日：2021-11-16

申请号：US13380623

申请日：2010-06-11

Applicant: Hans Dietl

Inventor： Hans Dietl

IPC: A61F2/72 ,  A61F2/76 ,  A61F2/70 ,  A61F2/54

Abstract: The invention relates to a method for setting up a control, and to a control for a technical orthopedic device, and a technical orthopedic device as such. Actuations of the technical orthopedic device (1) are provided by means of an output device (2, 3), biomettric signals are received by sensors (12), and said signals are associated with the respective actuations.

公开(公告)号：US20100030341A1

公开(公告)日：2010-02-04

申请号：US11911975

申请日：2006-04-26

Applicant: Hans Dietl ,  Horst Willburger ,  Hermann Lanmuller

Inventor： Hans Dietl ,  Horst Willburger ,  Hermann Lanmuller

IPC: A61F2/70 ,  A61F2/78

CPC classification number: A61F2/68 ,  A61F2/72 ,  A61F2/80 ,  A61F2002/6881 ,  A61F2002/705 ,  A61F2002/7818

Abstract: The invention relates to a myoelectrical electrode unit for a prosthetic device, which includes a liner positioned between an amputation stump and the prosthetic device and a myoelectrical electrode unit for detecting and transmitting myoelectrical signals to control the prosthetic device.

Abstract translation: 本发明涉及一种用于假体装置的肌电极单元，其包括定位在截肢残端和假体装置之间的衬垫和用于检测和传递肌电信号以控制假体装置的肌电极单元。

公开(公告)号：US06136357A

公开(公告)日：2000-10-24

申请号：US51173

申请日：1998-09-14

Applicant: Hans Dietl

Inventor： Hans Dietl

IPC: A61K9/107 ,  A61K9/48 ,  A61K31/00 ,  A61K38/00 ,  A61K38/13 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/28 ,  A61P37/00 ,  A61P37/06

CPC classification number: A61K9/1075 ,  A61K38/13 ,  A61K9/107 ,  A61K9/4858 ,  Y10S514/885

Abstract: Cyclosporin(s) are formulated as a pharmaceutical preparation that provides good and uniform resorption of the cyclosporin(s) with no nonphysiological pharmaceutical adjuvants, by combining the cyclosporin(s) with (i) monoglycerides, diglycerides, and/or triglycerides of natural fatty acids, (ii) natural fatty acids and/or alkaline salts of natural fatty acids, and (iii) 3-sn-phosphatidyl choline(s), and/or phosphatidyl ethanolamine(s), and optionally also (iv) natural bile acids and/or alkaline salts of natural bile acids, and (v) a natural alcohol. The pharmaceutical preparation does not contain water and is not an emulsion.

Abstract translation: PCT No.PCT / EP96 / 03001 Sec。 371日期：1998年9月14日 102（e）1998年9月14日PCT PCT 1996年7月9日PCT公布。 公开号WO97 / 12626 日期1997年4月10日将环孢菌素配制成药物制剂，其通过将环孢菌素与（i）单甘油酯，甘油二酯和/或甘油二酯结合在一起，提供没有非生理药学佐剂的环孢菌素的良好和均匀吸收， 或天然脂肪酸的甘油三酸酯，（ii）天然脂肪酸的天然脂肪酸和/或碱性盐，和（iii）3-sn-磷脂酰胆碱和/或磷脂酰乙醇胺，和任选地也可以（ iv）天然胆汁酸的天然胆汁酸和/或碱性盐，和（v）天然酒精。 药物制剂不含水，不是乳剂。